# Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avelox

> **NCT00668304** · PHASE4 · COMPLETED · sponsor: **Bayer** · enrollment: 192 (actual)

## Conditions studied

- Maxillary Sinusitis

## Interventions

- **DRUG:** Avelox (Moxifloxacin, BAY12-8039)

## Key facts

- **NCT ID:** NCT00668304
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** —
- **Final completion:** 2005-01
- **Target enrollment:** 192 (ACTUAL)
- **Last updated:** 2014-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00668304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00668304, "Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avelox". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00668304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*